The effect of hepatitis b virus infection on hepcidin expression in hepatitis B patients

Annals of Clinical and Laboratory Science

Volumn 43, Issue 2, 2013, Pages 126-134

  Wang, Xue Hua ^a   Cheng, Pan Pan ^b   Jiang, Fang ^a   Jiao, Xiao Yang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

Ferritin; Hepatitis B; Hepcidin; IL 6; Iron

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINE OXIDASE (FLAVIN CONTAINING); ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROCESSING; THROMBOCYTE COUNT; VIRUS LOAD;

FERRITIN; HEPATITIS B; HEPCIDIN; IL-6; IRON;

ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, HEPATOCELLULAR; FERRITINS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; INTERLEUKIN-6; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; VIRAL LOAD;

EID: 84878195282     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Degertekin B, Lok AS. Update on viral hepatitis: 2008. Curr Opin Gastroenterol 2009; 25: 180-5.
2. Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol 2008; 6: 541-52.
3. Guo L, Enzan H, Hayashi Y et al. Increased iron deposition in rat liver fibrosis induced by a high-dose injection of dimethylnitrosamine. Exp Mol Pathol 2006; 81: 255-61.
4. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811-9.
5. Atanasiu V, Manolescu B, Stoian I. Hepcidin--central regulator of iron metabolism. Eur J Haematol 2007; 78: 1-10.
6. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-3.
7. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006: 29-35, 507.
8. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica 2008; 93: 90-7.
9. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006; 91: 727-32.
10. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-6.
11. Fleming RE. Iron and inflammation: cross-talk between pathways regulating hepcidin. J Mol Med (Berl) 2008; 86: 491-4.
12. Berger A, Preiser W, Doerr HW. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol 2001; 20: 23-30.
13. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
14. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006; 43: S173-81.
15. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-29.
16. Olmez OF, Gurel S, Yilmaz Y. Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis. Eur J Gastroenterol Hepatol 2010; 22: 461-5.
17. Tangkijvanich P, Vimolket T, Theamboonlers A, et al. Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease. Asian Pac J Allergy Immunol 2000; 18: 109-14.
18. Zhang W, Yue B, Wang GQ, Lu SL. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 2002; 1: 577-80.
19. Song le H, Binh VQ, Duy DN, et al. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 2003; 28: 93-103.
20. Aoki CA, Rossaro L, Ramsamooj R, et al. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol 2005; 39: 71-4.
21. Fujita N, Sugimoto R, Takeo M, et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 2007; 13: 97-104.
22. Valenti L, Pulixi EA, Arosio P, et al. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 2007; 92: 1037-42.
23. Nagashima M, Kudo M, Chung H, et al. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 2006; 36: 288-93.
24. Girelli D, Pasino M, Goodnough JB, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009; 51: 845-52.
25. Jaroszewicz J, Rogalska M, Flisiak R. Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis. Biomarkers 2008; 13: 478-85.
26. Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005; 2: 399-409.
27. Carballo M, Conde M, El Bekay R, et al. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 1999; 274: 17580-6.
28. Schoonbroodt S, Ferreira V, Best-Belpomme M, et al. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl- terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J Immunol 2000; 164: 4292-300.
29. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-10.
30. Licata A, Nebbia ME, Cabibbo G, et al. Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol 2009; 15: 2132-8.
31. Kobune M, Kohgo Y, Kato J, et al. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 1994; 19: 1468-75.
32. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003; 361: 669-73.
33. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004; 113: 1251-3.
34. Messner DJ, Kowdley KV. Biting the iron bullet: endoplasmic reticulum stress adds the pain of hepcidin to chronic liver disease. Hepatology 2010; 51: 705-7.
35. Tan MG, Kumarasinghe MP, Wang SM, et al. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med (Maywood) 2009; 234: 693-702.
36. Knovich MA, Storey JA, Coffman LG, et al. Ferritin for the clinician. Blood Rev 2009; 23: 95-104.